291 related articles for article (PubMed ID: 15073691)
1. Recombinant interleukin-18 protects against disseminated Candida albicans infection in mice.
Stuyt RJ; Netea MG; van Krieken JH; van der Meer JW; Kullberg BJ
J Infect Dis; 2004 Apr; 189(8):1524-7. PubMed ID: 15073691
[TBL] [Abstract][Full Text] [Related]
2. Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis.
Vonk AG; Netea MG; van Krieken JH; Iwakura Y; van der Meer JW; Kullberg BJ
J Infect Dis; 2006 May; 193(10):1419-26. PubMed ID: 16619190
[TBL] [Abstract][Full Text] [Related]
3. Differential role of IL-18 and IL-12 in the host defense against disseminated Candida albicans infection.
Netea MG; Vonk AG; van den Hoven M; Verschueren I; Joosten LA; van Krieken JH; van den Berg WB; Van der Meer JW; Kullberg BJ
Eur J Immunol; 2003 Dec; 33(12):3409-17. PubMed ID: 14635050
[TBL] [Abstract][Full Text] [Related]
4. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.
Brieland J; Essig D; Jackson C; Frank D; Loebenberg D; Menzel F; Arnold B; DiDomenico B; Hare R
Infect Immun; 2001 Aug; 69(8):5046-55. PubMed ID: 11447185
[TBL] [Abstract][Full Text] [Related]
5. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice.
Huang W; Na L; Fidel PL; Schwarzenberger P
J Infect Dis; 2004 Aug; 190(3):624-31. PubMed ID: 15243941
[TBL] [Abstract][Full Text] [Related]
6. Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans.
Netea MG; van Tits LJ; Curfs JH; Amiot F; Meis JF; van der Meer JW; Kullberg BJ
J Immunol; 1999 Aug; 163(3):1498-505. PubMed ID: 10415052
[TBL] [Abstract][Full Text] [Related]
7. Liquiritigenin, a licorice flavonoid, helps mice resist disseminated candidiasis due to Candida albicans by Th1 immune response, whereas liquiritin, its glycoside form, does not.
Lee JY; Lee JH; Park JH; Kim SY; Choi JY; Lee SH; Kim YS; Kang SS; Jang EC; Han Y
Int Immunopharmacol; 2009 May; 9(5):632-8. PubMed ID: 19264152
[TBL] [Abstract][Full Text] [Related]
8. Fas-FasL interactions modulate host defense against systemic Candida albicans infection.
Netea MG; van Der Meer JW; Meis JF; Kullberg BJ
J Infect Dis; 1999 Nov; 180(5):1648-55. PubMed ID: 10515828
[TBL] [Abstract][Full Text] [Related]
9. Role of TLR1 and TLR6 in the host defense against disseminated candidiasis.
Netea MG; van de Veerdonk F; Verschueren I; van der Meer JW; Kullberg BJ
FEMS Immunol Med Microbiol; 2008 Jan; 52(1):118-23. PubMed ID: 18036178
[TBL] [Abstract][Full Text] [Related]
10. Human lactoferrin-derived peptide's antifungal activities against disseminated Candida albicans infection.
Lupetti A; Brouwer CP; Bogaards SJ; Welling MM; de Heer E; Campa M; van Dissel JT; Friesen RH; Nibbering PH
J Infect Dis; 2007 Nov; 196(9):1416-24. PubMed ID: 17922408
[TBL] [Abstract][Full Text] [Related]
11. Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.
Li Wq; Hu Xc; Zhang X; Ge Y; Zhao S; Hu Y; Ashman RB
Vaccine; 2011 Jul; 29(33):5526-33. PubMed ID: 21645574
[TBL] [Abstract][Full Text] [Related]
12. Influence of leflunomide on gastrointestinal Candida albicans infection induced in naive and arthritic newborn mice.
Dimitrova P; Ivanovska N
Int Immunopharmacol; 2006 Nov; 6(11):1682-9. PubMed ID: 16979122
[TBL] [Abstract][Full Text] [Related]
13. Host immune reactivity determines the efficacy of combination immunotherapy and antifungal chemotherapy in candidiasis.
Mencacci A; Cenci E; Bacci A; Bistoni F; Romani L
J Infect Dis; 2000 Feb; 181(2):686-94. PubMed ID: 10669356
[TBL] [Abstract][Full Text] [Related]
14. Immunoregulatory activity by daucosterol, a beta-sitosterol glycoside, induces protective Th1 immune response against disseminated Candidiasis in mice.
Lee JH; Lee JY; Park JH; Jung HS; Kim JS; Kang SS; Kim YS; Han Y
Vaccine; 2007 May; 25(19):3834-40. PubMed ID: 17335944
[TBL] [Abstract][Full Text] [Related]
15. Role of interleukin-18 in host defense against disseminated Candida albicans infection.
Stuyt RJ; Netea MG; Verschueren I; Fantuzzi G; Dinarello CA; Van Der Meer JW; Kullberg BJ
Infect Immun; 2002 Jun; 70(6):3284-6. PubMed ID: 12011026
[TBL] [Abstract][Full Text] [Related]
16. Increased tissue resistance in the nude mouse against Candida albicans without altering strain-dependent differences in susceptibility.
Fulurija A; Ashman RB; Papadimitriou JM
J Med Vet Mycol; 1997; 35(3):197-203. PubMed ID: 9229336
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice.
Khan MA; Khan A; Owais M
FEMS Immunol Med Microbiol; 2006 Feb; 46(1):63-9. PubMed ID: 16420598
[TBL] [Abstract][Full Text] [Related]
18. CpG oligodeoxynucleotides protect mice from lethal challenge with Candida albicans via a pathway involving tumor necrosis factor-alpha-dependent interleukin-12 induction.
Choi JH; Ko HM; Park SJ; Kim KJ; Kim SH; Im SY
FEMS Immunol Med Microbiol; 2007 Oct; 51(1):155-62. PubMed ID: 17854477
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic vaccination with phage-displayed epitope of C. albicans elicits protective immune responses against systemic candidiasis in C57BL/6 mice.
Yang Q; Wang L; Lu DN; Gao RJ; Song JN; Hua PY; Yuan DW
Vaccine; 2005 Jul; 23(31):4088-96. PubMed ID: 15963364
[TBL] [Abstract][Full Text] [Related]
20. Production of anti-Candida antibodies in mice with gut colonization of Candida albicans.
Tansho S; Abe S; Ishibashi H; Mitsuya M; Wada K; Ikeda T; Suegara N; Koshio O; Ono Y; Yamaguchi H
Mediators Inflamm; 2004 Jun; 13(3):189-93. PubMed ID: 15223610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
